Beyond Next Ventures is a venture capital firm dedicated to supporting researchers and entrepreneurs in the deep tech space, with a focus on Japan and India. They aim to create a reinforcing cycle of science and technology innovation by providing resources, financing, and ecosystem support. Their accelerator program, BRAVE, has enabled over 200 innovators to commercialize their deep tech startups, raising over 50 billion yen in additional financings. They manage more than 34 billion yen and invest in startups at or before the seed stage, with several successful IPOs and M&As in their portfolio.
| Fund Size | N/A USD |
| Stages Focus | Pre-Seed, Seed |
| Sectors Focus | Deep Tech, Medical, Agritech, Food Tech, Healthcare, Sustainability, Digital Infrastructure |
| Portfolio Size | 2 companies |
Beyond Next Ventures' investment thesis is centered on supporting deep tech innovations that can enrich the world and create a reinforcing cycle of science and technology innovation. They focus on investing in exceptional challengers in the deep tech field, particularly in Japan and India.
Active team contains 19 members (5 partners, 1 founders).
Beyond Next Ventures is a venture capital firm dedicated to supporting researchers and entrepreneurs in the deep tech space, with a focus on Japan and India.
Beyond Next Ventures is located in Tokyo, Japan.
The founding date of Beyond Next Ventures is not publicly available.
Beyond Next Ventures is a venture capital firm.
Beyond Next Ventures invests in Pre-Seed and Seed stages.
The check size for Beyond Next Ventures ranges from $300,000 to $1,500,002 USD.
No, Beyond Next Ventures does not accept cold outreach.
Beyond Next Ventures' investment thesis is centered on supporting deep tech innovations that can enrich the world and create a reinforcing cycle of science and technology innovation. They focus on investing in exceptional challengers in the deep tech field, particularly in Japan and India.
Yes, Beyond Next Ventures actively invests in Deep Tech.
Yes, Beyond Next Ventures actively invests in the Medical sector.